San Francisco-based 23andMe, which provides medical and ancestry-related genetic testing, filed for bankruptcy after it was unable to find a buyer to rescue it from insolvency proceedings and the board of directors rejected a buyout offer from co-founder Anne Wojcicki.

Despite collecting DNA from saliva samples from more than 15 million customers, the company hasn’t been profitable since going public in 2021. That personal information can now be sold as part of a court-supervised auction, 23andMe said in a filing.

In California, state Attorney General Rob Bonta reminded customers they have the right to tell the firm to permanently delete their data.

Any data amassed by 23andMe in the state is subject to deletion under both the Genetic Information Privacy Act and the California Consumer Protection Act, according to the office.

On the 23andMe website, customers can delete their data through the settings function and also direct the company to destroy stored saliva samples and DNA, as well as revoke permission for their genetic data to be used for research.

In the years before it raised $600 million from shareholders, the company spent heavily to draw in users with a goal of hitting 10 million customers, according to a 2021 investor presentation. But the company struggled to turn single-transaction customers into reliable — and profitable — subscribers.

“The often ‘one-time’ nature of sales involving the company’s saliva collection kits resulted in a shrinking customer base and declining top-line revenues,” Chief Restructuring Officer Matthew Kvarda said.

Today, 550,000 customers pay for the company’s two primary services, Kvarda said in a court filing. Those services produced 76% of revenues during the latest fiscal year, which ended March 31, 2024.

23andMe will continue marketing itself to investors, aiming to get at least one binding offer by May 7, according to court papers. That deadline was set by lenders, who are seeking court permission to loan 23andMe as much as $35 million to fund its bankruptcy.

The Chapter 11 filing in St. Louis will also resolve legal troubles related to a data breach in 2023, according to a statement.

That hack compromised information about roughly 7 million customers, including giving a hacker direct access to about 14,000 user accounts. The company faces about 35,000 claims related to the incident.

The company plans to continue operating throughout the sales process, it said.

The bankruptcy is the latest chapter in the saga of the DNA testing company valued at $3.5 billion when it went public. Wojcicki’s efforts to take the struggling company private were rejected by a committee earlier this month.

23andMe has $277.4 million in assets and $214.7 million in liabilities, court documents show. It received a debtor-in-possession financing commitment of as much as $35 million from JMB Capital Partners, according to the statement.

That loan must be approved by the judge overseeing the case. The debt, if approved, carries a 14% interest rate and would pay a 2% commitment fee, a 6% exit fee and a $100,000 work fee.

Jason Green of the Bay Area News Group contributed to this report.